{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:16:24Z","timestamp":1790802984170,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jemermed.2025.02.018","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T11:15:27Z","timestamp":1739790927000},"page":"222-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A Case of Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis"],"prefix":"10.1016","volume":"75","author":[{"given":"Daisuke","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-0330","authenticated-orcid":false,"given":"Yuuki","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Akakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Matsubayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2025.02.018_bib0001","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/M23-2788","article-title":"Newer pharmacologic treatments in adults with type 2 diabetes: a clinical guideline from the American College of Physicians","volume":"177","author":"Qaseem","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0002","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMc2112411","article-title":"Empagliflozin and major renal outcomes in heart failure","volume":"385","author":"Packer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0003","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/5584_2020_545","article-title":"Acute metabolic emergencies in diabetes: DKA, HHS and EDKA","volume":"1307","author":"Muneer","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.jemermed.2025.02.018_bib0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1053\/j.ajkd.2022.10.012","article-title":"Consensus recommendations for sick day medication guidance for people with diabetes, kidney, or cardiovascular disease: a modified Delphi process","volume":"81","author":"Watson","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jchromb.2014.06.023","article-title":"Simultaneous determination of metformin and vildagliptin in human plasma by a HILIC\u2013MS\/MS method","volume":"965","author":"Pontarolo","year":"2014","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0007","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/ajcp\/80.4.484","article-title":"Definition of clinically relevant lactic acidosis in patients with internal diseases","volume":"80","author":"Luft","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"Defronzo","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0011","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc19-2391","article-title":"Hospitalization for lactic acidosis among patients with reduced kidney function treated with metformin or sulfonylureas","volume":"43","author":"Chu","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002967.pub3","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"2010","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/dom.13650","article-title":"A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors","volume":"21","author":"Brown","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0014","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0015","first-page":"206","article-title":"\u2018Euglycemic\u2019 ketoacidosis in a patient with type 2 diabetes being treated with canagliflozin","volume":"115","author":"Danford","year":"2016","journal-title":"WMJ"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0016","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4103\/jfmpc.jfmpc_644_21","article-title":"Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: a systematic review and quantitative analysis","volume":"11","author":"Dutta","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","article-title":"Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management","volume":"44","author":"Long","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0018","doi-asserted-by":"crossref","first-page":"e15157","DOI":"10.1111\/dme.15157","article-title":"Effects of DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: a network meta-analyses-driven approach","volume":"40","author":"Br\u00f8nden","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0019","doi-asserted-by":"crossref","first-page":"e0287","DOI":"10.1097\/XCE.0000000000000287","article-title":"Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure","volume":"12","author":"Nzomessi","year":"2023","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"10.1016\/j.jemermed.2025.02.018_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00592-008-0032-0","article-title":"Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver","volume":"45","author":"Tessari","year":"2008","journal-title":"Acta Diabetol"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2025.02.018_bib0021","article-title":"THU382 It's not what It seems \u2013 metformin induced severe lactic acidosis mimicking euglycemic diabetic ketoacidosis","volume":"7","author":"Shaukat","year":"2023","journal-title":"J Endocr Soc"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T21:23:44Z","timestamp":1753219424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467925000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"alternative-id":["S0736467925000514"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.02.018","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Case of Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}